Abstract
Increasing bacterial burden in the lower airways of patients with idiopathic pulmonary fibrosis confers an increased risk of disease progression and mortality. However, it remains unclear whether this increased bacterial burden directly influences progression of fibrosis or simply reflects the magnitude of the underlying disease extent or severity.We prospectively recruited 193 patients who underwent bronchoscopy and received a multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Quantification of the total bacterial burden in bronchoalveolar lavage fluid was performed by 16S rRNA gene qPCR. Imaging was independently evaluated by two readers assigning quantitative scores for extent, severity and topography of radiographic changes and relationship of these features with bacterial burden was assessed.Increased bacterial burden significantly associated with disease progression (HR 2.1; 95% CI 1.287–3.474; p=0.0028). Multivariate stepwise regression demonstrated no relationship between bacterial burden and radiological features or extent of disease. When specifically considering patients with definite or probable usual interstitial pneumonia there was no difference in bacterial burden between these two groups. Despite a postulated association between pleuroparenchymal fibroelastosis and clinical infection, there was no relationship between either the presence or extent of pleuroparenchymal fibroelastosis and bacterial burden.We demonstrate that bacterial burden in the lower airways is not simply secondary to the extent of the underlying architectural destruction of the lung parenchyma seen in idiopathic pulmonary fibrosis. The independent nature of this association supports a relationship with the underlying pathogenic mechanisms and highlights the urgent need for functional studies.
Funder
Action for Pulmonary Fibrosis Mike Bray Fellowship
Wellcome Trust
Wellcome
British Lung Foundation
Asthma UK
National Institute for Health Research
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Reference39 articles.
1. Idiopathic Pulmonary Fibrosis
2. Respiratory microbiome in IPF: cause, effect, or biomarker?;Molyneaux;Lancet Respir Med,2014
3. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis
4. O'Dwyer DN , Moore BB , Molyneaux PL . Interstitial lung disease. In: Cox MJ , Ege MJ , von Mutius E , eds. The Lung Microbiome (ERS Monograph). Sheffield, European Respiratory Society, 2019; pp. 173–187.
5. The microbiome in respiratory medicine: current challenges and future perspectives
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献